Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

330
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
330
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

460
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
460
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

650
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
650
Management of Insomnia01:19

Management of Insomnia

229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

302
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
302

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis.

Current oncology (Toronto, Ont.)·2026
Same author

Cost-effectiveness of Antibacterial Envelope for Sacral Neuromodulation Infection Prevention.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Sexual Function After Prolapse Repair and Retropubic Versus Single-incision Sling.

Urogynecology (Philadelphia, Pa.)·2026
Same author

The Administrative Burden of Overactive Bladder Medications.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Femtech Revolution for Pelvic Floor Disorders and Sexual Health.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Patient Experience Following Gynecologic Surgery Complicated by Ureteral Injury.

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Response to Letter to the Editor re: "Factors Associated With Persistent Bothersome Urinary Symptoms and Leakage After Pregnancy".

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Methodological Considerations in Postpartum Urinary Incontinence: Addressing Occupational and Clinical Confounders.

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Response to Letter to the Editor re: "Nocturnal Polyuria and MACE: Neuroendocrine Links Explaining Sex Differences" and "Nocturia and Cardiovascular Events: Risk Factor or Clinical Marker?"

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Nocturnal Polyuria and MACE: Neuroendocrine Links Explaining Sex Differences.

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Nocturia and Cardiovascular Events: Risk Factor or Clinical Marker?

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Letter to the Editor re: Using Chatbot to Better Understand What Matters Most to Urogynecologic Patients.

Urogynecology (Philadelphia, Pa.)·2026
查看所有相关文章

相关实验视频

Updated: May 27, 2025

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases
07:56

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases

Published on: June 28, 2024

613

博托克斯治疗睡眠的有效性

Feven W Getaneh1, Lee Ann Richter2, Mai Dabbas3

  • 1From the Department of Obstetrics and Gynecology, Medstar National Center for Advanced Pelvic Surgery.

Urogynecology (Philadelphia, Pa.)
|February 19, 2025
PubMed
概括
此摘要是机器生成的。

毒素A (BTX) 注射显著减少过度活动膀综合征 (OAB) 的妇女的夜间排尿. 这种治疗还可以改善这些患者的睡眠质量和整体生活质量.

更多相关视频

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.6K
Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
08:58

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice

Published on: June 19, 2019

9.6K

相关实验视频

Last Updated: May 27, 2025

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases
07:56

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases

Published on: June 28, 2024

613
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.6K
Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
08:58

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice

Published on: June 19, 2019

9.6K

科学领域:

  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科
  • 睡眠医学 睡眠医学
  • 生活质量研究 研究 生命质量研究

背景情况:

  • 夜是女性过度活动膀 (OAB) 的主要投诉.
  • 预先的研究表明,体内毒素A (BTX) 可能减少夜尿,但其对睡眠和生活质量的影响尚不清楚.

研究的目的:

  • 评估BTX注射在减少夜尿频率方面的有效性.
  • 评估BTX对OAB妇女睡眠质量和生活质量的影响.

主要方法:

  • 一项前性观察性研究,涉及OAB的成年女性,每晚至少有两次夜发作.
  • 参与者接受了BTX注射,并在基线和治疗后5周完成了膀/睡眠日记和问卷.

主要成果:

  • 在BTX后观察到,夜发作显著减少 (平均每晚减少2次).
  • 睡眠障碍减少了59% (P = 0.006),睡眠间隔最长,第一次觉醒的时间和平均睡眠间隔显著改善.
  • 与夜相关的生活质量得分显著改善 (P < 0.001),40%的人实现了夜解决 (≤1次/晚).

结论:

  • 在OAB的女性中,BTX注射有效地减少了夜间空洞.
  • 用BTX治疗显著提高睡眠质量,并改善这个患者群体的夜相关的生活质量.